PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

Gray Station Middle put a cap on the regular season Monday night, earning a split with Monroe County Middle School.In the boys game, GSMS took over in the third quarter to open up a close contest, ...

A steroid nasal spray such as fluticasone (Flonase) or triamcinolone can help with nasal congestion symptoms without the risk of rebound symptoms. OTC antihistamines and decongestants can help ...

In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...

You've probs seen them in the aisles of Boots and at the end of your favourite TikTokers' makeup tutorials, but what's the deal with makeup setting sprays? Do they actually work? We decided it was ...

Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...

While the best unlocked phones almost certainly support GSM carriers like AT&T and T-Mobile, it’s best to look for devices that work with all the major U.S. providers, including Verizon.

Now, the Food and Drug Administration (FDA) has expanded approval for Johnson & Johnson's nasal spray, Spravato, to be used as a standalone treatment for people with severe depression who haven't ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...